Heart Attack
35
5
6
21
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 35 trials
95.5%
+8.9% vs benchmark
9%
3 trials in Phase 3/4
33%
7 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (35)
The Role of Stress in Cardiac Arrest (Cortizol CPR)
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Immunomodulatory Effects of PCSK9 Inhibition
National Cardiogenic Shock Initiative
Home Telemonitoring In Patients After Myocardial Infarction
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome
CV Wizard: Does a Clinical Decision Support Tool Improve CVD Risk Factor Control in Safety Net Clinics?
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Stress Management and Resiliency Training Following Acute Myocardial Infarction
The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
PatientSpot Formerly Known as ArthritisPower
Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation
The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population
Chronic Kidney Disease (CKD) Platelet Study
ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow
Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
A Digital Flu Intervention for People With Cardiovascular Conditions
Improving the Accuracy of Referrals of Patients With Chest Pain